Kellie D Morland

Kellie D Morland, PharmD

Adjunct Associate Instructional Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-6268
Business Email: kelliemorland@ufl.edu

Teaching Profile

Courses Taught
2022-2025
PHA6797 Applied Pharmaceutical Research Communications

Publications

2021
EXPRESS: Reasons for Refusing Parenteral Therapy: A Qualitative Study of Patients with Pulmonary Arterial Hypertension
Pulmonary Circulation. [DOI] 10.1177/20458940211046761. [PMID] 35024138.
2019
Opioid-related respiratory and gastrointestinal adverse events in patients with acute postoperative pain: prevalence, predictors, and burden.
Journal of pain & palliative care pharmacotherapy. 33(3-4):82-97 [DOI] 10.1080/15360288.2019.1668902. [PMID] 31609155.
2016
IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENT.
International journal of technology assessment in health care. 32(6):371-375 [DOI] 10.1017/S0266462316000593. [PMID] 27919315.
2014
The economic impact of acute coronary syndrome on length of stay: an analysis using the Healthcare Cost and Utilization Project (HCUP) databases.
Journal of medical economics. 17(3):191-7 [DOI] 10.3111/13696998.2014.885907. [PMID] 24451040.
2013
A physician-focused intervention to reduce potentially inappropriate medication prescribing in older people: a 3-year, Italian, prospective, proof-of-concept study.
Drugs & aging. 30(2):119-27 [DOI] 10.1007/s40266-012-0043-y. [PMID] 23233284.
2013
An economic model to value companion diagnostics in non-small-cell lung cancer.
Personalized medicine. 10(2):139-147 [DOI] 10.2217/pme.13.7. [PMID] 29758848.
2011
Alzheimer’s disease: new therapies and the role of biomarkers.
Biotechnology healthcare. 8(1):22-3 [PMID] 22478846.

Education

PharmD
2004-2010 · Duquesne University, Mylan School of Pharmacy

Contact Details

Phones:
Business:
(352) 273-6268
Emails:
Addresses:
Business Mailing:
PO Box 100496
GAINESVILLE FL 32610